- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Gut-first Parkinson’s disease is encoded by gut dysbiome ; volume:19 ; number:1 ; day:24 ; month:10 ; year:2024 ; pages:1-28 ; date:12.2024
Molecular neurodegeneration ; 19, Heft 1 (24.10.2024), 1-28, 12.2024
- Urheber
-
Munoz-Pinto, Mário F.
Candeias, Emanuel
Melo-Marques, Inês
Esteves, A. Raquel
Maranha, Ana
Magalhães, João D.
Carneiro, Diogo Reis
Sant’Anna, Mariana
Pereira-Santos, A. Raquel
Abreu, António E.
Nunes-Costa, Daniela
Alarico, Susana
Tiago, Igor
Morgadinho, Ana
Lemos, João
Figueiredo, Pedro N.
Januário, Cristina
Empadinhas, Nuno
Cardoso, Sandra Morais
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13024-024-00766-0
- URN
-
urn:nbn:de:101:1-2501132118358.444312681271
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Munoz-Pinto, Mário F.
- Candeias, Emanuel
- Melo-Marques, Inês
- Esteves, A. Raquel
- Maranha, Ana
- Magalhães, João D.
- Carneiro, Diogo Reis
- Sant’Anna, Mariana
- Pereira-Santos, A. Raquel
- Abreu, António E.
- Nunes-Costa, Daniela
- Alarico, Susana
- Tiago, Igor
- Morgadinho, Ana
- Lemos, João
- Figueiredo, Pedro N.
- Januário, Cristina
- Empadinhas, Nuno
- Cardoso, Sandra Morais
- SpringerLink (Online service)
Ähnliche Objekte (12)
Parkinson’s Disease and Gut Microbiota
Disease progression in proposed brain-first and body-first Parkinson’s disease subtypes
Gut, oral and nasal microbiota and Parkinson’s disease
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Gut microbiota helps identify clinical subtypes of Parkinson’s disease
Gut microbiota in Parkinson’s disease patients: hospital-based study
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Neuroplasticity in Parkinson’s disease
Investigating the aspect of asymmetry in brain-first versus body-first Parkinson’s disease
Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms
Diet and the gut microbiome in patients with Parkinson’s disease
Parkinson’s Disease and Gut Microbiota
Disease progression in proposed brain-first and body-first Parkinson’s disease subtypes
Gut, oral and nasal microbiota and Parkinson’s disease
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Gut microbiota helps identify clinical subtypes of Parkinson’s disease
Gut microbiota in Parkinson’s disease patients: hospital-based study
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Neuroplasticity in Parkinson’s disease
Investigating the aspect of asymmetry in brain-first versus body-first Parkinson’s disease
Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms
Diet and the gut microbiome in patients with Parkinson’s disease
Parkinson’s Disease and Gut Microbiota
Disease progression in proposed brain-first and body-first Parkinson’s disease subtypes
Gut, oral and nasal microbiota and Parkinson’s disease
Precision medicine in Parkinson’s disease: emerging treatments for genetic Parkinson’s disease
Gut microbiota helps identify clinical subtypes of Parkinson’s disease
Gut microbiota in Parkinson’s disease patients: hospital-based study
Nutraceuticals in Parkinson’s Disease
Redefinition of Parkinson’s Disease
Neuroplasticity in Parkinson’s disease
Investigating the aspect of asymmetry in brain-first versus body-first Parkinson’s disease
Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms